Andere talen NEXGEL, Inc.

Aandelen

NXGL

US65344E1073

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,22 ^USD	-0,45%		+0,45%	+4,23%

01/04	NEXGEL, Inc. rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023	CI
01/04	Transcript : NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024	18/04
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Earnings Flash (NXGL) NEXGEL Posts Q4 Revenue $1.1M	01/04
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year	01/04
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023	01/04
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday	27/03
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th	21/03
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th	04/03
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders	21/02
NEXGEL to Present at The Microcap Conference, January 30th through February 1st	18/01
NEXGEL, Inc. Announces Intention of Miranda J. Toledano to Resign as a Member of the Board of Directors, Effective as of March 31, 2024	16/01
Top Premarket Decliners	16/01
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	09/01
Nexgel Subsidiary, Cg Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	09/01
NEXGEL, Inc. Announces Resignation of David Stefansky as Member of the Board of Directors	12/12
Nexgel Enters Deal With Stada Arzneimittel to Distribute OTC Products Across North America	11/12
NEXGEL, Inc. Announces Partnership with STADA Arzneimittel AG to Distribute and Commercialize Consumer Health OTC Products in North America	11/12
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America	11/12
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line	05/12
NEXGEL, Inc. acquired Kenkoderm from Olympus Trading Company, LLC for $1.1 million.	05/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NEXGEL, Inc.

Aandelen

NXGL

US65344E1073

Andere talen

Filters